INTEGRIN GENETIC VARIANTS AND STAGE-SPECIFIC TUMOR RECURRENCE IN PATIENTS WITH STAGE II AND III COLON CANCER

摘要

The disclosure provides compositions and methods for determining the likely tumor recurrence in cancer patients by screening one or more of ITGB3, ITGB1 or ITGA4 polymorphisms in samples isolated from the patient.